Catheter Precision plans 1-for-10 reverse split

Split-adjusted trading is expected to begin October 5 under the Flyte Aviation, Inc. name and ticker VJET.

Rhea-AI Filing Summary

Catheter Precision, Inc. approved an amendment to change its name to Flyte Aviation, Inc. and effect a 1-for-10 reverse stock split, expected to become effective at 12:01 a.m. Eastern Time on October 5, 2026. Stockholders approved the split at a special meeting on April 15, 2026, and the Board selected the ratio within the approved range; the name change did not require stockholder approval.

The company intends to file a certificate of amendment. At the effective time, every ten shares issued and outstanding or held in treasury will be combined into one share. No fractional shares will be issued; holders otherwise entitled to a fraction will receive their pro rata portion of net proceeds from the exchange agent’s aggregation and sale of those shares. The split will not change the common stock’s par value or authorized share count, and outstanding equity awards, warrants, and convertible securities will be adjusted proportionately under their terms. Split-adjusted trading is expected to begin on the NYSE American under the name Flyte Aviation, Inc. and ticker VJET at the opening of trading on October 5, 2026.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Reverse stock split ratio: 1-for-10 Expected effective time: 12:01 a.m. Eastern Time Common stock par value: $0.0001 per share +1 more

4 metrics

Reverse stock split ratio 1-for-10 Expected to become effective October 5, 2026

Expected effective time 12:01 a.m. Eastern Time October 5, 2026

Common stock par value $0.0001 per share Par value remains unchanged by the reverse stock split

Stockholder approval date April 15, 2026 Special meeting approving the reverse stock split

Key Terms

reverse stock split, fractional shares, par value, authorized shares, +1 more

5 terms

reverse stock split financial

"effect a 1-for-10 reverse stock split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

fractional shares financial

"No fractional shares will be issued"

Fractional shares are portions of a whole share of a stock or fund, allowing investors to own less than one full unit. They make it possible to invest a specific dollar amount rather than buy whole shares, like buying a slice of a pizza instead of the entire pie. For investors this lowers the cost barrier, helps with diversification, and lets you reinvest dividends or purchase expensive stocks in small, precise amounts.

par value financial

"will not change the par value"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

authorized shares financial

"or the number of authorized shares of Common Stock"

Authorized shares are the maximum number of shares a company is allowed to issue according to its official plan. Think of it as a company’s set limit on how many pieces of its ownership it can distribute to investors. This number helps investors understand the potential for future growth or change in the company's ownership structure.

split-adjusted basis financial

"begin trading on a split-adjusted basis"

An adjustment to historical share prices and share counts that reflects past stock splits or reverse splits so that old data lines up with the current number of shares. Think of it like resizing an old photograph so it matches a new frame: it keeps price charts, returns and per‑share metrics comparable over time, which matters to investors who need accurate performance, valuation and trend analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What reverse stock split is VTAK planning?

Catheter Precision approved a 1-for-10 reverse stock split expected to become effective at 12:01 a.m. Eastern Time on October 5, 2026. Stockholders approved the split at a special meeting on April 15, 2026, and the Board selected the ratio within the range approved by stockholders.

What will VTAK trade as after the reverse split?

The common stock is expected to begin split-adjusted trading on the NYSE American under the name Flyte Aviation, Inc. and ticker VJET at the opening of trading on October 5, 2026.

How will VTAK handle fractional shares in the reverse split?

No fractional shares will be issued. Stockholders otherwise entitled to a fractional share will receive their pro rata portion of the net proceeds from the aggregation and sale of those fractional shares by the company's exchange agent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/25/2026 - 05:27 PM Accepted by SEC EDGAR 09/25/2026 - 05:26 PM Learn about SEC filing dates

false 0001716621 0001716621 2026-09-24 2026-09-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 24, 2026

Catheter Precision, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-38677		38-3661826
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1670 Highway 160 West Suite 205 Fort Mill, SC		29708
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (973) 691-2000

(Former name or former address, if changed since last report)

Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		VTAK		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01         Other Events.

On September 24, 2026, the Board of Directors (the “Board”) of Catheter Precision, Inc. (the “Company”) approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to (i) change the Company's name from “Catheter Precision, Inc.” to “Flyte Aviation, Inc.” (the “Name Change”), and (ii) effect a 1-for-10 reverse stock split of the Company's common stock, par value $0.0001 per share (the “Common Stock”) (the “Reverse Stock Split”). The Name Change was approved by the Board pursuant to Section 242(b)(1) of the General Corporation Law of the State of Delaware and did not require stockholder approval. The Company's stockholders approved the Reverse Stock Split at a special meeting held on April 15, 2026, and the Board selected the ratio within the range approved by the stockholders. The Company intends to file a certificate of amendment with the Secretary of State of the State of Delaware to effect the Name Change and the Reverse Stock Split, which are expected to become effective at 12:01 a.m., Eastern Time, on October 5, 2026 (the “Effective Time”).

At the Effective Time, every ten (10) shares of Common Stock issued and outstanding or held in treasury will automatically be combined into one (1) share of Common Stock. No fractional shares will be issued. Stockholders who would otherwise be entitled to a fractional share will instead be entitled to receive their pro rata portion of the net proceeds from the aggregation and sale of such fractional shares by the Company's exchange agent. The Reverse Stock Split will not change the par value of the Common Stock or the number of authorized shares of Common Stock, and proportionate adjustments will be made to the Company's outstanding equity awards, warrants, and convertible securities in accordance with their terms.

The Common Stock is expected to begin trading on a split-adjusted basis on the NYSE American under the name “Flyte Aviation, Inc.” and the new ticker symbol “VJET” at the opening of trading on October 5, 2026. The new CUSIP number for the Common Stock following the Reverse Stock Split will be 74933X 807.

Item 9.01         Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 25, 2026
	CATHETER PRECISION, INC.
	By:	/s/ Philip Anderson
		Philip Anderson
		Chief Financial Officer

Filing Exhibits & Attachments

4 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.5 KB
• EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE 11.5 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 15.5 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 11.7 KB